Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine in Treatment-Resistant Schizophrenia
NCT00250575Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of clozapine in schizophrenia, sponsored by Novartis. Started Nov 2005; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00250575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250575.